Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30.
Published May 1, 2013 · Recall initiated: April 8, 2013
Summary
FDA records drug Class II recall D-297-2013, published May 1, 2013 and initiated April 8, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 245,250 vials; Lot: Lot #: 11-185-DJ*, 11-196-DJ*, Exp 1NOV2013; * may be followed by 01 or 02. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: A single visible particulate was identified during a retain sample inspection.
What to do
Voluntary: Firm initiated · Letter
Get an email if PROPOFOL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PROPOFOL
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot #: 11-185-DJ*, 11-196-DJ*, Exp 1NOV2013; * may be followed by 01 or 02
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPROPOFOL Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL glass fliptop vial (NDC 0409-4699-54)September 21, 2022
- FDAPropofol Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL per glass fliptop vial (NDCAugust 3, 2022
- FDAPropofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vials, packaged in 5February 25, 2015
- FDAPropofol Injectable Emulsion, 1%, 200 mg/20 mL, (10mg/mL), 20 mL, Single patient infusion vial, ContainsFebruary 4, 2015
- FDACyclosporin in Corn Oil Injectable Balanced Solutions, Compounding Pharmacy a division of Axium HealthcareMay 1, 2013
- FDAGLIMEPIRIDE TABLETS USP, 2 mg, 100-count tablets per bottle, Rx only, Manufactured for: QualitestMay 1, 2013
Questions about this recall
Was Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30. recalled?
Yes. FDA published recall D-297-2013 on May 1, 2013. Reported hazard: Presence of Particulate Matter: A single visible particulate was identified during a retain sample inspection.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PROPOFOL.